Bringing gene therapy to where it's needed.
Trends in molecular medicine, 28(3): 171-172 PMID 35086771 DOI 10.1016/j.molmed.2022.01.005
Abstract
Gene editing allows the precise modification of cells to correct genetic defects or enhance immunotherapies. A limitation is the delivery of this technology to specific cells or organs. Recently, Banskota et al. reported the use of virus-like particles (VLPs) loaded with gene-editing agents for gene therapy delivery directly inside the body.